FR2430228A1 - Medicament contre les maladies de la peau - Google Patents

Medicament contre les maladies de la peau

Info

Publication number
FR2430228A1
FR2430228A1 FR7812906A FR7812906A FR2430228A1 FR 2430228 A1 FR2430228 A1 FR 2430228A1 FR 7812906 A FR7812906 A FR 7812906A FR 7812906 A FR7812906 A FR 7812906A FR 2430228 A1 FR2430228 A1 FR 2430228A1
Authority
FR
France
Prior art keywords
skin disease
disease medicine
skin
compositions
mepacrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7812906A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Publication of FR2430228A1 publication Critical patent/FR2430228A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)

Abstract

L'invention concerne un médicament contre les maladies de la peau. Elle couvre des compositions pharmaceutiques administrées aux hommes et aux animaux par voie topique comprenant un excipient pharmaceutique avec au moins un ingrédient actif choisi dans le groupe comprenant le bromure de parabromophénacyle, l' alpha -tocophérol, la mépacrine, la chloroquine, l'hydroxychloroquine, la dibucaine, la tétracaine, la lidocaïne, la butacaïne, la procaïne,l'acide éthylènediaminetétracétique et l'acide éthylèneglycol-bis - ( beta -aminoéthyléther) - N,N'-tétraacétique ; ces compositions peuvent également contenir un ou plusieurs composés aliphatiques insaturés, un glucocorticoïde et une prostaglandine. Ces médicaments conviennent en particulier pour lutter contre le psoriasis.
FR7812906A 1977-05-02 1978-05-02 Medicament contre les maladies de la peau Withdrawn FR2430228A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/793,100 US4181725A (en) 1977-05-02 1977-05-02 Method for alleviating psoriasis

Publications (1)

Publication Number Publication Date
FR2430228A1 true FR2430228A1 (fr) 1980-02-01

Family

ID=25159088

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7812906A Withdrawn FR2430228A1 (fr) 1977-05-02 1978-05-02 Medicament contre les maladies de la peau

Country Status (6)

Country Link
US (1) US4181725A (fr)
JP (1) JPS53136521A (fr)
AU (1) AU3543378A (fr)
BE (1) BE866611A (fr)
DE (1) DE2818553A1 (fr)
FR (1) FR2430228A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659710A (en) * 1979-10-22 1981-05-23 Eisai Co Ltd Preventive and remedy for psoriasis
AU538186B2 (en) * 1980-03-07 1984-08-02 Scotia Holdings Plc Prostaglandin precursors
US4451482A (en) * 1982-04-22 1984-05-29 Shell Oil Company Method of preventing or ameliorating pyrethroid skin sensory stimulation
US4788061A (en) * 1985-07-05 1988-11-29 Shore Ronald N Extended occlusive treatment of skin disorders
US5002974A (en) * 1988-04-04 1991-03-26 Warner-Lambert Co. Anesthetic/skin moisturizing composition and method of preparing same
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
SE8804214L (sv) * 1988-11-22 1990-05-23 Jean Cassuto Antiinflammatoriskt och antiinfektioest medikament
US4908162A (en) * 1988-11-22 1990-03-13 David Rubin Method of making triple bonded unsaturated fatty acids
FR2664164A1 (fr) * 1990-07-04 1992-01-10 Texinfine Patrinove Composition dermatologique ou cosmetique.
GB9101986D0 (en) * 1991-01-30 1991-03-13 Smith & Nephew Pharmaceutical compositions
JPH06506014A (ja) * 1991-03-20 1994-07-07 ミネソタ　マイニング　アンド　マニュファクチャリング　カンパニー 放射線硬化性ビニル／シリコーン剥離コーティング
US5324746A (en) * 1993-02-12 1994-06-28 Mckee Rex N Method of treating damaged mucosal and epithelial tissues with misoprostol
CA2130291A1 (fr) * 1993-08-18 1995-02-19 Juan Carlos Mahiques Utilisation therapeutique des composes connus de types ester et amide
US5478837A (en) * 1994-06-07 1995-12-26 University Of Southern California Use of quinacrine in preventing adhesion formation
US6176240B1 (en) * 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6705323B1 (en) * 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
WO1998017231A2 (fr) * 1996-10-18 1998-04-30 Charous B Lauren Traitement et administration d'hydroxychloroquine
US6153197A (en) * 1996-12-18 2000-11-28 Albazi; Rakhi Topical treatment of psoriasis
US5994399A (en) * 1997-03-27 1999-11-30 Mckee; Rex N. Method of regenerating collagen-containing tissues with misoprostol
US5935137A (en) * 1997-07-18 1999-08-10 Gynecare, Inc. Tubular fallopian sterilization device
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
JP2002543122A (ja) * 1999-04-30 2002-12-17 エイピーティー ファーマスーティカルズ エルエルスィー 抗マラリア治療剤についての新規使用
WO2001028550A1 (fr) * 1999-10-15 2001-04-26 Mayo Foundation For Medical Education And Research Anesthesiques topiques employes dans le traitement du cancer, les affections auto-immunes et l'ischemie
US10179159B2 (en) * 1999-10-22 2019-01-15 Scott Wepfer Topical anesthetic formulation
US20020046357A1 (en) * 1999-12-28 2002-04-18 Jiandong Huang Software-based fault tolerant networking using a single LAN
KR100847678B1 (ko) * 2000-02-11 2008-07-23 리서치 디벨럽먼트 파운데이션 토코페롤, 토코트리에놀, 다른 크로만 및 측쇄 유도체, 및이들의 용도
US20040220220A1 (en) * 2001-11-09 2004-11-04 Charous B. Lauren Method for treating inflammatory bowel disease
MXPA04004393A (es) * 2001-11-09 2005-09-12 Charous Lauren Nuevos usos para agentes terapeuticos anti-malarios.
AU2002363444B2 (en) * 2001-11-09 2007-12-06 Apt Pharmaceuticals, Inc. A method for treating inflammatory bowel disease
US20040214860A1 (en) * 2001-11-09 2004-10-28 Charous B. Lauren Method for treating inflammatory bowel disease
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
WO2003053407A1 (fr) * 2001-12-19 2003-07-03 Research Development Foundation Administration de preparations liposomales de composes a base de vitamine e
AU2003209150A1 (en) * 2002-01-04 2003-07-24 Combinatorx, Incorporated Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
US20060100181A1 (en) * 2002-05-03 2006-05-11 Jost-Price Edward R Combinations for the treatment of inflammatory skin disorders
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US7108992B2 (en) * 2002-11-27 2006-09-19 St. Jude Children's Research Hospital ATM kinase compositions and methods
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
US7241746B2 (en) * 2003-08-06 2007-07-10 Regena Therapeutics, Lc Method and composition for treating periodontal disease
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
DE102004059613A1 (de) * 2004-12-10 2006-06-14 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer topischen Therapie von Neurodermitis
US20070023534A1 (en) * 2005-07-22 2007-02-01 Mingsheng Liu Water-source heat pump control system and method
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
AU2016288699B2 (en) * 2015-06-30 2020-11-26 Eiger Group International, Inc. Use of chloroquine and clemizole compounds for treatment of inflammatory and cancerous conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB859897A (en) * 1958-07-05 1961-01-25 Roche Products Ltd Novel unsaturated acids and esters thereof and a process for the manufacture and conversion of same
US3450821A (en) * 1967-03-02 1969-06-17 Hoffmann La Roche Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof
BE754114A (fr) * 1969-07-29 1971-01-29 Upjohn Co Nouveaux composes de la classe des prostaglandines et leur procede de preparation
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs

Also Published As

Publication number Publication date
JPS53136521A (en) 1978-11-29
US4181725A (en) 1980-01-01
BE866611A (fr) 1978-09-01
AU3543378A (en) 1979-11-01
DE2818553A1 (de) 1978-11-09

Similar Documents

Publication Publication Date Title
FR2430228A1 (fr) Medicament contre les maladies de la peau
CA2191129A1 (fr) Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine
EP0362270B1 (fr) Lotion pour application de steroides
FR2362833A1 (fr) Nouveaux derives 5 de prostaglandine, leur procede de preparation et medicament les contenant
MA27156A1 (fr) NUCLEOSIDES 3- β-D-RIBOFURANOSYLTHIAZOLO[4,5-d] PYRIDIMINE ET LES UTILISATIONS DE CELLES-CI
TNSN97091A1 (fr) CONJUGUE PEG-IFN α PHYSIOLOGIQUEMENT ACTIF, PROCEDE POUR SA PREPARATION, COMPOSITIONS PHARMACEUTIQUES LE CONTENANT ET LEUR UTILISATION
FR2356424A1 (fr) Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales
BR9810841A (pt) Inibidores de metaloprotease alicìclicos
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
WO1995018622A1 (fr) Agents de chimioprevention ou de chimiotherapie du cancer du colon a base de derives de l'acide 2-hydroxy-5-phenylazobenzoique
CA2231342A1 (fr) Composition pharmaceutique pour administration par voie orale
SE8001599L (sv) Transdermalt medicineringssystem for isosorbiddinitrat
BE906034A (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
FR2554346B1 (fr) Ensemble et procede pour l'administration de gangliosides et de leurs derives par inhalation et compositions pharmaceutiques les contenant
IE43693L (en) Androstane derivatives
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
FR2422640A1 (fr) Nouvelles morphinane-6-ones a substituant 8b-alkyle, leur procede de production et medicament les contenant
FR2405067A1 (fr) Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees
FR2420344A1 (fr) Nouveaux oxime-ethers, leur preparation et leur application therapeutique.
FR2393579A1 (fr) Agent antiviral et son application au traitement des affections virales
FR2404010A1 (fr) Nouveaux derives de pyrimido-(2,1-a)isoquinoleine, leur procede de production et composition pharmaceutique les contenant
FR2362587A1 (fr) Agents antimicrobie
BE900138A (fr) Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques.
FR2391191A1 (fr) Nouveaux composes polypeptidiques, lyeptidiques, leur preparation et leur application comme medicaments
FR2369837A1 (fr) Derives actifs de l'uree, leur procede de preparation ainsi que les compositions therapeutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse